These companies have been implementing various strategies that have helped the growth of the company and in turn, have brought about various changes in the market. The companies have utilized strategies such as product launches, expansions, and product upgrades for the growth of their organizations. For instance, In January 2021, Illumina, Inc. has transforming genomic data bottlenecks into catalysts with the launch of Illumina Connected Analytics (ICA). The new and integrated bioinformatics solution provides a comprehensive, private, cloud-based data platform that empowers customers to manage, analyze, and explore large volumes of multi-omic data in a secure, scalable, and flexible environment.
Thermofisher Scientific, Inc. and Agilent Technologies, Inc.– are Notable Market Players in Global Bioinformatics Market
Bioinformatics, as associated to genetics and genomics, is a scientific subdiscipline that involves using computer technology to collect, store, analyze and disseminate biological data and information, such as DNA and amino acid sequences or observations about those sequences. Bioinformatics is essential for management of data in modern biology and medicine. Scientists and clinicians use databases that organize and guide the biological information to increase the understanding of health and disease and, in certain cases, as part of medical care.
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the global bioinformatics market, including Agilent Technologies, Inc, Biomax Informatics Ag, Bruker Corporation, Dassault Systems, Eurofins Scientific, Geneva Bioinformatics, Illumina, Perkinelmer, Qiagen, Thermofisher Scientific, Inc. The companies have been implementing various strategies that have helped the growth of the company and in turn, have brought about various changes in the market. The companies have utilized organic strategies such as launches and product approvals. Whereas inorganic strategies such as mergers & acquisitions, and collaborations, were widely seen in the market.
Several organic approaches, such as product launches, and expansion in the global bioinformatics market, have resulted in the positive growth of the market. Likewise, inorganic strategies such as mergers & acquisitions, and collaboration have helped the company to strengthen its revenue, which allows the company to hold a strong position in the market.
Below is the list of the growth strategies adopted by the players operating in the global bioinformatics market:
| YEAR | NEWS |
| Apr-2021 | Illumina, Inc., a global leader in DNA sequencing and array-based technologies, today announced the launch of its new state-of-the-art Solution Center in São Paulo, Brazil. The choice to bring the facility to Brazil reflects an increasing demand for and interest in clinical genomics, as well as Illumina’s longstanding commitment to expanding global access to genomics in Latin America |
| Oct-2021 | QIAGEN has announced the completion of the move of its European Center of Excellence for Precision Medicine into facilities in Manchester’s CityLabs 2.0, a new genomics campus developed with Health Innovation Manchester. The new center will anchor this world-leading genomics campus in the heart of Manchester’s health-innovation district and underlines the city’s role as QIAGEN’s global hub for diagnostics development, a crucial element of the company’s global success. |
| Jan 2022 | Thermo Fisher completed its acquisition of PeproTech on December 30, 2021, for a total cash purchase price of approximately US$ 1.85 billion. PeproTech is a privately held provider of bioscience reagents known as recombinant proteins, including cytokines and growth factors. Recombinant proteins are used in the development and manufacturing of cell and gene therapies as well as in broader cell culture applications, especially for use in cellular research models. |
